What are Regenxbio's profit margins?

Regenxbio (RGNX) runs a 59.7% gross margin and a -292.3% operating margin, with a -330.2% net margin.

Where do Regenxbio's ratios come from?

Every ratio is computed from Regenxbio's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Regenxbio RGNX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Operating margin	-94.6%+185pp	-280%+17.1pp	-297.1%-63.9pp	-233.2%-267pp
Net margin	-113.8%+159pp	-272.5%+19.4pp	-292%-43.3pp	-248.7%-276pp
EBITDA margin	-85.4%+175pp	-260.6%+17.4pp	-277.9%-56.2pp	-221.8%-258pp
Free cash flow margin	-74.1%+137pp	-210.7%+42.4pp	-253.1%-41.7pp	-211.3%-240pp
Returns
Return on equity	-107%-27.5pp	-79.5%-15.8pp	-63.7%-19.9pp	-43.8%-66.2pp
Return on assets	-42.2%+1.5pp	-43.7%-6.2pp	-37.4%-8.7pp	-28.8%-42.8pp
Return on invested capital	-75.7%-4.0pp	-71.7%-10.8pp	-60.9%-9.3pp	-51.6%-103pp
Efficiency
Asset turnover	0.4×+0.2×	0.2×0.0×	0.1×0.0×	0.1×-0.4×
Liquidity
Current ratio	2.4×-0.3×	2.7×+0.1×	2.6×-0.6×	3.2×-0.8×
Quick ratio	2.4×-0.3×	2.7×+0.1×	2.6×-0.6×	3.2×-0.8×
Cash ratio	0.3×-0.3×	0.6×+0.3×	0.3×-0.5×	0.7×-1.9×
Leverage
Debt-to-equity	0.7×+0.4×	0.3×0.0×	0.3×+0.1×	0.2×+0.1×
Debt-to-assets	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.1×0.0×
Interest coverage	-3.6×+14.9×	-18.4×+20.6×	-39.1×-27.8×	-11.3×-17.4×
Per Share
Book value per share	$1.99-62.0%	$5.24-26.4%	$7.13-40.4%	$11.96-31.3%
Valuation
Market capitalization	$529.38M+24.6%	$382.98M-51.5%	$789.82M-19.6%	$981.9M-29.8%
Enterprise value	$585.22M+56.3%	$407.49M-51.8%	$844.59M-13.8%	$979.75M-14.1%
Price / sales	6×+3.3×	4.6×-4.2×	8.8×0.0×	8.7×+5.7×
Price / book	25.1×+23.6×	1.5×-1.1×	2.5×+0.6×	1.9×+0.1×
EV / sales	6.7×+4.3×	4.9×-4.5×	9.4×+0.7×	8.7×+6.3×
Free cash flow yield	-44.7%-24.2pp	-45.8%-16.9pp	-28.9%-4.7pp	-24.3%-33.9pp
Earnings yield	-54.8%-17.7pp	-59.3%-25.9pp	-33.4%-4.8pp	-28.5%-37.7pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Regenxbio.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Regenxbio's profit margins?: Regenxbio (RGNX) runs a 59.7% gross margin and a -292.3% operating margin, with a -330.2% net margin.
Where do Regenxbio's ratios come from?: Every ratio is computed from Regenxbio's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.